Centre Seals Deal With Biological-E for 30 Crore COVID-19 Vaccine Doses

Centre Seals Deal With Biological-E for 30 Crore COVID-19 Vaccine Doses A student receives COVID-19 vaccine dose during a special vaccination drive organised by the Karnataka government for the students (Photo Credit: PTI)

New Delhi: The Union Health Ministry reached an arrangement with Hyderabad-based vaccine manufacturer Biological-E to reserve nearly 30 crore coronavirus vaccine jabs for which it will be making an advance payment of Rs 1500 crore.

The above-mentioned Covid vaccine doses will be manufactured and stockpiled by Biological-E themselves from August to December this year, a ministry statement confirmed on Thursday.

The coronavirus vaccine of Biological-E is presently undergoing phase-3 clinical trial after showing optimism outputs during phase 1 and 2 trials.

COVID 19 Vaccination
A medic administers COVID-19 vaccine dose to a student during a special vaccination drive organised by the Karnataka government for the students, who are going abroad for education and employment, in Bengaluru, Wednesday, June 2, 2021. (PTI Photo/Shailendra Bhojak) (

ALSO READ: Serum Institute of India seeks test licence from DCGI to manufacture Sputnik V Covid vaccine

The vaccine is being manufactured by Biological-E is a RBD protein sub-unit vaccine and will reportedly be available in the next few months.

“The proposal of Biological-E was scrutinised and then recommended for approval after due diligence by the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC),” the statement said.

Centre’s arrangement with Biological-E is part of the wider endeavour of the Indian government to encourage indigenous Covid vaccine manufacturers by providing backing in research and development and also financial support, it also said.

The Department of Biotechnology has provided financial assistance in terms of grant-in-aid of over Rs 100 crore and also partnered with Biological-E to perform all animal challenge and assay studies through Faridabad’s Research Institute Translational Health Science Technology Institute (THSTI.

ALSO READ: Coronavirus India Update: Slight spike recorded with 1.34 lakh new cases on June 3

This entire initiative has been undertaken as part of Centre’s ‘Mission COVID Suraksha, the Indian COVID-19 Vaccine Development Mission,’ which was launched to accelerate and reinforce coronavirus vaccine development efforts as part of the third stimulus package, Atmanirbhar 3.0, the statement said.

India’s COVID-19 Vaccine Tally

India on Thursday (June 3) crossed the 22 crore figure in vaccination doses across the country according to the date of the Union Ministry of Health and Family Welfare. A total of 22,10,43,693 vaccine doses have been administered till 7 am on June 3. Out the this, 24,26,265 doses were given on June 2 alone.

The liberalised and accelerated phase-3 strategy of COVID-19 vaccination has come into force from May 1, 2021 after which everyone above the age of 18 was eligible to receive a vaccine shot.

(With PTI Inputs)

For the latest News, Breaking News, Top News, like us on Facebook or follow us on Twitter and YouTube